3860 — EPS Creative Health Technology Income Statement
0.000.00%
- HK$258.48m
- HK$256.81m
- HK$644.62m
- 16
- 53
- 10
- 12
Annual income statement for EPS Creative Health Technology, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 537 | 405 | 520 | 453 | 645 |
Cost of Revenue | |||||
Gross Profit | 92.2 | 54 | 76.8 | 67.8 | 99.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 509 | 398 | 538 | 495 | 662 |
Operating Profit | 27.9 | 7.27 | -18.1 | -42.4 | -17 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 27.8 | 7.14 | -22.7 | -48.2 | -24.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 22.7 | 6.5 | -26.3 | -50.3 | -26.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 22.7 | 6.5 | -22.6 | -45.7 | -22.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 22.7 | 6.5 | -22.6 | -45.7 | -22.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.054 | 0.013 | -0.045 | -0.093 | -0.044 |
Dividends per Share |